Mati Shaklai

2.1k total citations
83 papers, 1.7k citations indexed

About

Mati Shaklai is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Mati Shaklai has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 26 papers in Genetics and 20 papers in Hematology. Recurrent topics in Mati Shaklai's work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Acute Myeloid Leukemia Research (8 papers). Mati Shaklai is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Acute Myeloid Leukemia Research (8 papers). Mati Shaklai collaborates with scholars based in Israel, United States and Slovakia. Mati Shaklai's co-authors include Osnat Bairey, Yael Zimra, Esther Rabizadeh, Ada Rephaeli, Dorit Blickstein, Abraham Nudelman, Miron Prokocimer, J Pinkhas, Jacob Luboshitz and Judith Lahav and has published in prestigious journals such as Blood, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mati Shaklai

81 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mati Shaklai

Since Specialization

Citations

This map shows the geographic impact of Mati Shaklai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mati Shaklai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mati Shaklai more than expected).

Fields of papers citing papers by Mati Shaklai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mati Shaklai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mati Shaklai. The network helps show where Mati Shaklai may publish in the future.

Co-authorship network of co-authors of Mati Shaklai

This figure shows the co-authorship network connecting the top 25 collaborators of Mati Shaklai. A scholar is included among the top collaborators of Mati Shaklai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mati Shaklai. Mati Shaklai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can Gas Replace Protein Function? CO Abrogates the Oxidative Toxicity of Myoglobin 2014 ·PLoS ONE ·(unknown), (unknown), Mati Shaklai, Nurith Shaklai	8
2	Antiphospholipid antibodies may be a new prognostic parameter in aggressive non‐Hodgkin's lymphoma 2006 ·European Journal Of Haematology ·Osnat Bairey, Dorit Blickstein, Yehudit Monselise, Judith Lahav, Pinhas Stark, Miron Prokocimer, (unknown), (unknown), (unknown), Mati Shaklai	25
3	Serum CA 125 levels in patients with chronic lymphocytic leukemia 2005 ·Clinical & Laboratory Haematology ·Osnat Bairey, Mati Shaklai	2
4	Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide 2002 ·American Journal of Hematology ·Osnat Bairey, (unknown), (unknown), Ashraf Hamdan, Ziv Ben‐Ari, Mati Shaklai	14
5	Doxorubicin and a butyric acid derivative effectively reduce levels of BCL‐2 protein in the cells of chronic lymphocytic leukemia patient 2001 ·European Journal Of Haematology ·Esther Rabizadeh, Osnat Bairey, Amir Aviram, (unknown), Mati Shaklai, Yael Zimra	12
6	Bcl‐2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia 2001 ·British Journal of Haematology ·Osnat Bairey, Yael Zimra, Mati Shaklai, Esther Rabizadeh	37
7	Protein disulfide isomerase mediates integrin‐dependent adhesion 2000 ·FEBS Letters ·Judith Lahav, (unknown), Jacob Luboshitz, (unknown), Mati Shaklai	118
8	Pernicious Anemia, Gastric Carcinoid, and Autoimmune Thrombocytopenia in a Young Woman 2000 ·Journal of Clinical Gastroenterology ·Ram Dickman, Mati Shaklai, Mordechai Lapidot, Elimelech Okon, (unknown), Gerald Fraser, Yaron Niv	5
9	Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis 2000 ·Journal of Cancer Research and Clinical Oncology ·Yael Zimra, Abraham Nudelman, (unknown), (unknown), Mati Shaklai, Adina Aviram, Ada Rephaeli	18
10	Significance of BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients 1999 ·Leukemia & lymphoma ·Amir Aviram, Dorit Blickstein, Pinhas Stark, Jacob Luboshitz, Osnat Bairey, Miron Prokocimer, Mati Shaklai	14
11	Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells 1997 ·Journal of Cancer Research and Clinical Oncology ·Yael Zimra, Lina Wasserman, Lea Maron, Mati Shaklai, Abraham Nudelman, Ada Rephaeli	30
12	Affinity Modulation in Platelet α2β1 Following Ligand Binding 1997 ·Biochemical and Biophysical Research Communications ·(unknown), A. Klepfish, (unknown), Mati Shaklai, Judith Lahav	18
13	Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia 1996 ·Cancer ·(unknown), Osnat Bairey, Dorit Blickstein, Miron Prokocimer, Herzlia Hadar, Meir Lahav, Jaqueline Sulkes, Mati Shaklai	3
14	Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma 1994 ·Cancer ·Osnat Bairey, Israel Kremer, Erica Rakowsky, (unknown), Mati Shaklai	70
15	Haemarthrosis in patients with mild coagulation factor deficiency 1991 ·Blood Coagulation & Fibrinolysis ·Osnat Bairey, Mati Shaklai, Aida Inbal	5
16	Proliferation‐associated changes of Ca²⁺ transport in myeloid leukemic cell lines 1990 ·Journal of Cellular Physiology ·Ada Rephaeli, (unknown), (unknown), Mati Shaklai	2
17	Phorbol-Myristate-Acetate-Induced Platelet Aggregation in the Presence of Inhibitors 1988 ·Acta Haematologica ·Z. Jerushalmy, (unknown), Mati Shaklai	3
18	Cholestasis and liver failure with lambda-AL amyloidosis. 1987 ·Gut ·Fred M. Konikoff, C. Mor, (unknown), Mati Shaklai, Jonathan Halevy, E Theodor	13
19	Hemophagocytosis Simulating Malignant Histiocytosis: A Terminal Event of the Myelodysplastic Syndrome 1985 ·Acta Haematologica ·Miron Prokocimer, Aida Inbal, (unknown), (unknown), (unknown), Mati Shaklai	10
20	Drug-induced agranulocytosis. A survey of twenty-three episodes. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Uri Mintz, Mati Shaklai, J Pinkhas, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact